If your insurance coverage changes and no longer covers your current formulation, work with your provider to transition to the covered option rather than discontinuing GLP-1 therapy entirely
Please check your connection, disable any ad blockers, or try using a different browser.
Why its notable: animal and preclinical studies support BPC-157s role in mucosal and soft-tissue healing, and its become a go-to for patients with digestive issues or slow-healing soft-tissue injuries
Diabetologia 2022;65:192566
Beyond shedding pounds, these medications positively impact numerous weight-related conditions: Cardiovascular disease risk reduction of approximately 20% (MACE) with GLP1s Improvements in sleep apnea (reduction of 6 fewer events per hour) Better management of non-alcoholic fatty liver disease Significant improvements in blood pressure, cholesterol, and blood sugar Reduced risk for cardiovascular and all-cause mortality Delayed progression to diabetes The weight loss threshold for meaningful health improvements typically starts at 5-10% of body weight
Ipamorelin is often used for its ability to support muscle recovery, improve sleep quality, increase energy levels, and promote healthier skin and joints